27 related articles for article (PubMed ID: 10216491)
1. Salivary and serum levels of soluble E-cadherin in patients with gastrointestinal cancers: A comparative study.
Aznab M; Shahhosseini R; Safaei M; Mozaffari HR
J Cancer Res Ther; 2023 Oct; 19(7):1982-1987. PubMed ID: 38376307
[TBL] [Abstract][Full Text] [Related]
2. The E-Cadherin Cleavage Associated to Pathogenic Bacteria Infections Can Favor Bacterial Invasion and Transmigration, Dysregulation of the Immune Response and Cancer Induction in Humans.
Devaux CA; Mezouar S; Mege JL
Front Microbiol; 2019; 10():2598. PubMed ID: 31781079
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.
Liang Z; Sun XY; Xu LC; Fu RZ
Med Sci Monit; 2014 Dec; 20():2776-82. PubMed ID: 25553984
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis.
Nava P; Kamekura R; Nusrat A
Tissue Barriers; 2013 Apr; 1(2):e24783. PubMed ID: 24665393
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.
Liu Y; Burkhalter R; Symowicz J; Chaffin K; Ellerbroek S; Stack MS
J Oncol; 2012; 2012():501492. PubMed ID: 22593767
[TBL] [Abstract][Full Text] [Related]
6. Soluble E-cadherin: an early marker of severity in acute pancreatitis.
Sewpaul A; French JJ; Khoo TK; Kernohan M; Kirby JA; Charnley RM
HPB Surg; 2009; 2009():397375. PubMed ID: 19421334
[TBL] [Abstract][Full Text] [Related]
7. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front.
De Wever O; Pauwels P; De Craene B; Sabbah M; Emami S; Redeuilh G; Gespach C; Bracke M; Berx G
Histochem Cell Biol; 2008 Sep; 130(3):481-94. PubMed ID: 18648847
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Cowden Dahl KD; Symowicz J; Ning Y; Gutierrez E; Fishman DA; Adley BP; Stack MS; Hudson LG
Cancer Res; 2008 Jun; 68(12):4606-13. PubMed ID: 18559505
[TBL] [Abstract][Full Text] [Related]
9. Soluble cadherins as cancer biomarkers.
De Wever O; Derycke L; Hendrix A; De Meerleer G; Godeau F; Depypere H; Bracke M
Clin Exp Metastasis; 2007; 24(8):685-97. PubMed ID: 17952616
[TBL] [Abstract][Full Text] [Related]
10. Concurrence of ovarian cancer and dermatomyositis. A report of two cases and literature review.
Mordel N; Margalioth EJ; Harats N; Ben-Baruch N; Schenker JG
J Reprod Med; 1988 Jul; 33(7):649-55. PubMed ID: 3050072
[TBL] [Abstract][Full Text] [Related]
11. [Cadherin].
Ouchi K; Sugawara T; Fujiya T
Nihon Rinsho; 1999 Dec; 57 Suppl():433-5. PubMed ID: 10778157
[No Abstract] [Full Text] [Related]
12. Preoperative serum E-cadherin assay in patients with ovarian carcinoma.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Ciampi B; Bianchi R; Genazzani AR
Anticancer Res; 1999; 19(1B):769-72. PubMed ID: 10216491
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
[TBL] [Abstract][Full Text] [Related]
14. The predictive and prognostic value of serum CA 125 half-life during paclitaxel/platinum-based chemotherapy in patients with advanced ovarian carcinoma.
Gadducci A; Cosio S; Fanucchi A; Negri S; Cristofani R; Genazzani AR
Gynecol Oncol; 2004 Apr; 93(1):131-6. PubMed ID: 15047226
[TBL] [Abstract][Full Text] [Related]
15. Serum endostatin levels in patients with epithelial ovarian cancer.
Hata K; Dhar DK; Kanasaki H; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Nagasue N; Miyazaki K
Anticancer Res; 2003; 23(2C):1907-12. PubMed ID: 12820477
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
